Delivery Order SPE2DB20D6037-SPE2DB24FTVQ7
Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $2.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides delivery orders for a range of pharmaceutical products to support the medical supply needs of military healthcare facilities. The $1,259.88 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and is not associated with a set-aside designation. The contract covers the delivery of Armour Thyroid 120 mg tablets in 100-count packages, with a performance period through March...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $1,259.88 and covers the delivery of Armour Thyroid 120 mg tablets. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical products to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $1,159.83 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Armour Thyroid 30 mg tablets in 100-count bottles. This order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract #4600082013 with DLA, which has a ceiling value of up to $4,999,999 and enables DLA to issue delivery orders for a wide...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.15 to DMS Pharmaceutical Group Inc. for the supply of Armour Thyroid 60 mg tablets (100-count units), with an ultimate completion date of July 22, 2025. The contract employs a firm fixed-price structure with no set-aside designation, and the place of performance is Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with ID SPE2DB22D9133|SPE2DB25FYV90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,519.76 firm fixed-price delivery order is for the supply of 4567481240 ARMOUR THYROID 120 MG TABLET 100S to support the medical needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,259.88 and covers the delivery of Armour Thyroid 120 mg tablets over a period ending on February 10, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,470.90 firm fixed-price delivery order is for the supply of Armour Thyroid 120 mg tablets. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the delivery of Armour Thyroid 120 mg tablets for a period ending on January 29, 2025, with a ceiling value of $1,049.90. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical...
- This federal contract award, with ID SPE2DB20D6037|SPE2DB23FC9VR, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Armour Thyroid 60 mg tablets, with a ceiling value of $6,089.25 and an ultimate completion date of December 8, 2022. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,259.88 firm fixed-price delivery order is for the supply of Armour Thyroid 120 mg tablets. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB24FTVQ7Delivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,075.43 issued under the Defense Logistics Agency's (DLA) SPE2DB pharmaceutical supply program. The award, which has a completion date of May 22, 2024, is for the supply of Armour Thyroid 60 mg tablets. DMS Pharmaceutical Group is a key supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA), providing a wide range of pharmaceutical products and medical supplies through its extensive federal contract portfolio, including a $499,999,999 indefinite delivery contract with the DLA. This contract award does not have a set-aside designation.
Generated 10/23/24, 9:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 5/21/24 |